Reuben Granich

Summary

Affiliation: World Health Organization
Country: Switzerland

Publications

  1. pmc Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050
    Reuben Granich
    HIV AIDS Department, World Health Organization, Geneva, Switzerland
    PLoS ONE 7:e30216. 2012
  2. pmc Confronting TB/HIV in the era of increasing anti-TB drug resistance
    Jeremiah Chakaya
    Centre for Respiratory Diseases Research, Kenya Medical Research Institute, Africa
    J Int AIDS Soc 11:6. 2008
  3. pmc Antiretroviral therapy in prevention of HIV and TB: update on current research efforts
    Reuben Granich
    Antiretroviral Treatment and HIV Care, Department of HIV AIDS, Building D, 1st Floor, Room 1005, World Health Organization, Avenue Appia 20, CH 1211, Geneva 27, Switzerland
    Curr HIV Res 9:446-69. 2011
  4. pmc Harnessing the prevention benefits of antiretroviral therapy to address HIV and tuberculosis
    Reuben Granich
    Antiretroviral Treatment and HIV Care Unit, Department of HIV AIDS, World Health Organization, Avenue Appia 20, CH 1211, Geneva 27, Switzerland
    Curr HIV Res 9:355-66. 2011
  5. pmc Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update
    Reuben Granich
    Antiretroviral Treatment and HIV Care Unit, Department of HIV AIDS, World Health Organization, Geneva, Switzerland
    Curr Opin HIV AIDS 5:298-304. 2010
  6. doi request reprint Prevention of tuberculosis in people living with HIV
    Reuben Granich
    Antiretroviral Treatment and HIV Care, HIV AIDS Department, World Health Organization, Geneva, Switzerland
    Clin Infect Dis 50:S215-22. 2010
  7. pmc Highly active antiretroviral treatment for the prevention of HIV transmission
    Reuben Granich
    Department of HIV AIDS, World Health Organization, Geneva, Switzerland
    J Int AIDS Soc 13:1. 2010
  8. ncbi request reprint Global policy review of antiretroviral therapy eligibility criteria for treatment and prevention of HIV and tuberculosis in adults, pregnant women, and serodiscordant couples
    Somya Gupta
    Department of HIV AIDS, World Health Organization, Geneva, Switzerland
    J Acquir Immune Defic Syndr 62:e87-97. 2013
  9. pmc Costing human rights and community support interventions as a part of universal access to HIV treatment and care in a Southern African setting
    Louisa Jones
    World Health Organization, Geneva, Switzerland
    Curr HIV Res 9:416-28. 2011
  10. doi request reprint HIV infection-associated tuberculosis: the epidemiology and the response
    Haileyesus Getahun
    Stop TB Department, World Health Organization, Geneva, Switzerland
    Clin Infect Dis 50:S201-7. 2010

Collaborators

Detail Information

Publications14

  1. pmc Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050
    Reuben Granich
    HIV AIDS Department, World Health Organization, Geneva, Switzerland
    PLoS ONE 7:e30216. 2012
    ..Antiretroviral Treatment (ART) significantly reduces HIV transmission. We conducted a cost-effectiveness analysis of the impact of expanded ART in South Africa...
  2. pmc Confronting TB/HIV in the era of increasing anti-TB drug resistance
    Jeremiah Chakaya
    Centre for Respiratory Diseases Research, Kenya Medical Research Institute, Africa
    J Int AIDS Soc 11:6. 2008
    ..These interventions are best carried out by HIV control programmes which should therefore be encouraged to take greater responsibility in implementing these interventions...
  3. pmc Antiretroviral therapy in prevention of HIV and TB: update on current research efforts
    Reuben Granich
    Antiretroviral Treatment and HIV Care, Department of HIV AIDS, Building D, 1st Floor, Room 1005, World Health Organization, Avenue Appia 20, CH 1211, Geneva 27, Switzerland
    Curr HIV Res 9:446-69. 2011
    ..The large number and wide variety of research projects emphasise the importance of this research issue and clearly demonstrate the potential for synergies, partnerships and coordination across funding agencies...
  4. pmc Harnessing the prevention benefits of antiretroviral therapy to address HIV and tuberculosis
    Reuben Granich
    Antiretroviral Treatment and HIV Care Unit, Department of HIV AIDS, World Health Organization, Avenue Appia 20, CH 1211, Geneva 27, Switzerland
    Curr HIV Res 9:355-66. 2011
    ..This review analyzes the gaps and summarizes the evidence regarding ART in the prevention of HIV and TB...
  5. pmc Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update
    Reuben Granich
    Antiretroviral Treatment and HIV Care Unit, Department of HIV AIDS, World Health Organization, Geneva, Switzerland
    Curr Opin HIV AIDS 5:298-304. 2010
    ..This review examines HAART as a potential tool for preventing HIV transmission...
  6. doi request reprint Prevention of tuberculosis in people living with HIV
    Reuben Granich
    Antiretroviral Treatment and HIV Care, HIV AIDS Department, World Health Organization, Geneva, Switzerland
    Clin Infect Dis 50:S215-22. 2010
    ....
  7. pmc Highly active antiretroviral treatment for the prevention of HIV transmission
    Reuben Granich
    Department of HIV AIDS, World Health Organization, Geneva, Switzerland
    J Int AIDS Soc 13:1. 2010
    ..To explore HAART as a prevention strategy, we recommend further discussions to explore human rights and ethical considerations, clarify research priorities and review feasibility and acceptability issues...
  8. ncbi request reprint Global policy review of antiretroviral therapy eligibility criteria for treatment and prevention of HIV and tuberculosis in adults, pregnant women, and serodiscordant couples
    Somya Gupta
    Department of HIV AIDS, World Health Organization, Geneva, Switzerland
    J Acquir Immune Defic Syndr 62:e87-97. 2013
    ..This article reviews the antiretroviral therapy (ART)initiation criteria from national treatment guidelines for 70 countries and determines the extent of consistency with the current World Health Organization (WHO) recommendations...
  9. pmc Costing human rights and community support interventions as a part of universal access to HIV treatment and care in a Southern African setting
    Louisa Jones
    World Health Organization, Geneva, Switzerland
    Curr HIV Res 9:416-28. 2011
    ..ART programs should consider measuring the cost and impact of human rights and community support interventions as key aspects of successful programme expansion...
  10. doi request reprint HIV infection-associated tuberculosis: the epidemiology and the response
    Haileyesus Getahun
    Stop TB Department, World Health Organization, Geneva, Switzerland
    Clin Infect Dis 50:S201-7. 2010
    ..Use of the highly decentralized TB services as an entry point to rapidly expand access to antiretroviral therapy and methods for prevention of HIV infection must be pursued aggressively...
  11. doi request reprint The global fight against HIV/AIDS, tuberculosis, and malaria: current status and future perspectives
    Marco Vitoria
    World Health Organization, HIV Dept, Geneva, Switzerland
    Am J Clin Pathol 131:844-8. 2009
    ..Investment in strategic information and public health laboratory network capacity strengthening are key actions to expand services to successfully address those diseases in heavily impacted countries...
  12. doi request reprint Fifteen million people on antiretroviral treatment by 2015: treatment as prevention
    Reuben Granich
    UNAIDS, Geneva, Switzerland
    Curr Opin HIV AIDS 8:41-9. 2013
    ..This review examines the potential, opportunities and challenges of treatment as prevention of HIV and tuberculosis (TB) in reaching this target...
  13. pmc Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies
    Haileyesus Getahun
    World Health Organization, Geneva, Switzerland
    PLoS Med 8:e1000391. 2011
    ..We conducted an individual participant data meta-analysis of primary studies, aiming to identify a sensitive TB screening rule...
  14. pmc Achieving universal access for human immunodeficiency virus and tuberculosis: potential prevention impact of an integrated multi-disease prevention campaign in kenya
    Reuben Granich
    Treatment and Care Unit, Department of HIV AIDS, World Health Organization, Avenue Appia 20, 1211 Geneva, Switzerland
    AIDS Res Treat 2012:412643. 2012
    ..Community-based integrated public health campaigns could be a potential solution to reach universal access and Millennium Development Goals...